Pan-cancer analyses across 17 cancer types and 225 samples revealed transcriptional heterogeneity among tumor-associated neutrophils, forming 10 distinct states; HLA-DR+CD74+ antigen-presenting neutrophils correlated with improved survival, while VEGFA+SPP1+ angiogenic neutrophils were associated with poorer prognosis. The gene discussed is CD74; the disease is cancer.